A kidney transplant recipient has no sulfonamide allergy and… | MyMerci
MyMerci — full questions and rationale, free Start for free
Medication Administration PPT
Question

A kidney transplant recipient has no sulfonamide allergy and is at risk for cytomegalovirus infection. Which prophylaxis plan should the nurse expect during early follow-up?

Explanation
Kidney transplant recipients routinely receive trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis, and recipients at CMV risk receive oral ganciclovir or valganciclovir according to donor-recipient serology and the transplant protocol. Nystatin or clotrimazole can be used for Candida prophylaxis but does not prevent CMV. Ciprofloxacin and rifampin are not standard PCP prophylaxis, and live vaccines are not substituted for prescribed antimicrobial prevention during immunosuppression.
Next question on this topicBefore giving a scheduled dose of digoxin, the nurse obtains an apical pulse of 54/min in …

In-depth explanation

Clinical reasoning
Immunosuppression creates predictable opportunistic-infection windows. TMP-SMX covers PCP and also reduces early urinary infection risk, while valganciclovir targets CMV risk determined by transplant serology and therapy.

Decision rule
Verify the organ-specific prophylaxis plan, renal-adjusted doses, blood counts, kidney function, and adherence rather than substituting unrelated antimicrobials or live vaccines.

Clinical scenario

Scenario 40-year-old female 1 week post-kidney transplant; pre-discharge med reconciliation.

Key concepts

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.